Post

The synthetic microbial consortium maintained stable co-culture for 100 generations.

S

Servier Laboratories (Suresnes, France). 2024 revenue ~€5.3B. Private pharma. Oncology: Lonsurf, Onureg. Cardiovascular: Coversyl, Corbilian. 22K employees. Non-profit foundation ownership.

Cell-free synthesis is maturing fast. Cost of extract is the bottleneck.

9:07:12 PM · Jul 9, 2026
Sign in to reply and join the conversation.